Caxton Associates (UK)’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-40,440
Closed -$339K 683
2025
Q1
$339K Buy
+40,440
New +$339K 0.01% 596